Table 6.

Patients reporting ≥3 of 20 emergent or worsening symptoms on the Tyrer Withdrawal Symptom Questionnaire for the first 3 nights after the end of treatment Period 1

	Across Nights 1–3 after the end of treatment Period 1
	Difference in proportion of patients with withdrawal between filorexant and placebo (%)	95% CI	P Value
Filorexant
2.5 mg	-3.18	(-12.7, 12.8)	0.687
5 mg	-3.77	(-13.0, 11.4)	0.724
10 mg	-4.75	(-13.6, 9.2)	0.786
20 mg	-2.05	(-11.6, 12.6)	0.631

CI, confidence interval.